PPD Appoints Allergan CFO to Board of Directors
6 February 2018 - - US-based contract research organization Pharmaceutical Product Development, LLC (PPD) has named Maria Teresa Hilado, chief financial officer of Allergan, to its board of directors, the company said.
Hilado has served as CFO of Allergan since December 2014, and she plans to retire from the company in the first quarter of 2018. Prior to joining Allergan, Hilado served as senior vice president, finance and treasurer of PepsiCo Inc. from 2009 to 2014.
She previously served as vice president and treasurer for Schering-Plough Corp. from 2008 to 2009 and spent more than 17 years with General Motors Co. in leadership roles of increasing responsibility, including assistant treasurer from 2006 to 2008 and CFO, GMAC Commercial Finance LLC from 2001 to 2005.
Hilado earned a bachelor's degree in management engineering from Ateneo de Manila University in the Philippines, and an MBA from the University of Virginia's Darden School of Business Administration.
PPD provides comprehensive, integrated drug development, laboratory and lifecycle management services to pharmaceutical, biotechnology, medical device, academic, and government organisations.
With offices in 47 countries and approximately 20,000 professionals worldwide, PPD applies innovative technologies, therapeutic expertise and a firm commitment to quality to help clients and partners bend the cost and time curve of drug development to deliver life-changing therapies that improve health.